CSIMarket
 


Vivus Inc  (VVUS)
Other Ticker:  
 
 

VVUS's Net Cash Flow Growth by Quarter and Year

Vivus Inc's Net Cash Flow results by quarter and year




VVUS Net Cash Flow (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -7.46 -27.61 -6.76
III Quarter September - 15.09 0.84 -3.26
II Quarter June - 2.00 -19.62 8.65
I Quarter March 0.21 -7.39 10.41 -17.03
FY   0.21 2.24 -35.98 -18.40



VVUS Net Cash Flow first quarter 2020 Y/Y Growth Comment
Vivus Inc in the first quarter 2020 achieved Net Cash Flow of $ 0.21 millions compare to net cash outflow recorded in same quarter a year ago.

Looking into first quarter 2020 results within Major Pharmaceutical Preparations industry 12 other companies have achieved higher Net Cash Flow growth. While Vivus Inc' s Net Cash Flow no change of % ranks overall at the positon no. 148 in the first quarter 2020.




VVUS Net Cash Flow ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - 1696.43 % - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Vivus Inc's first quarter 2020 Net Cash Flow $ 0.21 millions VVUS's Income Statement
Vivus Inc's first quarter 2019 Net Cash Flow $ -7.39 millions Quarterly VVUS's Income Statement
New: More VVUS's historic Net Cash Flow Growth >>


VVUS Net Cash Flow (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - 654.5 % - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #28
Overall #148

Net Cash Flow Y/Y Growth Statistics
High Average Low
-43.7 % -250.24 % -694.17 %
(June 30. 2014)   (Mar 31 2019)
Net Cash Flow first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #28
Overall #148
Net Cash Flow Y/Y Growth Statistics
High Average Low
-43.7 % -250.24 % -694.17 %
(June 30. 2014)   (Mar 31 2019)

Net Cash Flow by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Vivus Inc's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VVUS's I. Quarter Q/Q Net Cash Flow Comment
This turnaround I. Quarter 2020where Vivus Inc posted Net Cash Flow of $ 0.21 millions should be inception of positive business climet.Vivus Inc announced in the I. Quarter 2020 Net Cash Flow of $ 0.21 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Vivus Inc achieved highest sequential Net Cash Flow growth. While Vivus Inc's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VVUS's I. Quarter Q/Q Net Cash Flow Comment
This turnaround I. Quarter 2020where Vivus Inc posted Net Cash Flow of $ 0.21 millions could be considered as a starting point of positive performance.Vivus Inc announced in the I. Quarter 2020 Net Cash Flow of $ 0.21 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Vivus Inc achieved highest sequential Net Cash Flow growth. While Vivus Inc's Net Cash Flow growth quarter on quarter, overall rank is .


Vivus Inc's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Net Cash Flow 12 Months Ending $ 9.83 $ 2.24 $ -17.91 $ -32.16 $ -53.78
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) 339.37 % - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 148 # 0 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
In the Mar 31 2020 period, Vivus Inc had cumulative twelve months Net Cash Flow of $ 10 millions compare to net cash outflow of $ -54 millions a year ago.
Even more so, not just that VVUS has restored the profitability, Vivus Inc is, as of now heading full steam with better then normal Net Cash Flow surge, from the twelve months ending in the quarter before of 339.37 % from $2.24 millions.

Vivus Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-43.7 %
-250.24 %
-694.17 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 28
S&P 500 # 148
Cumulative Net Cash Flow growth Comment
In the Mar 31 2020 period, Vivus Inc had cumulative twelve months Net Cash Flow of $ 10 millions compare to net cash outflow of $ -54 millions a year ago.
Besides Vivus Inc has regained the profitability, it is already improving fast with better then normal Net Cash Flow gain, from the twelve months ending in the quarter before of 339.37 % from $2.24 millions.

Vivus Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-43.7 %
-250.24 %
-694.17 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 28
S&P 500 # 148




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
VVUS's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for VVUS's Competitors
Net Cash Flow Growth for Vivus Inc's Suppliers
Net Cash Flow Growth for VVUS's Customers

You may also want to know
VVUS's Annual Growth Rates VVUS's Profitability Ratios VVUS's Asset Turnover Ratio VVUS's Dividend Growth
VVUS's Roe VVUS's Valuation Ratios VVUS's Financial Strength Ratios VVUS's Dividend Payout Ratio
VVUS's Roa VVUS's Inventory Turnover Ratio VVUS's Growth Rates VVUS's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2020
Vystar Corporation-14.78%$ -14.783 millions
Haemonetics Corporation-24.77%$ -24.765 millions
Nuwellis Inc -26.94%$ -26.943 millions
Epizyme Inc.-30.98%$ -30.978 millions
Viracta Therapeutics Inc -35.11%$ -35.106 millions
Paratek Pharmaceuticals Inc -36.08%$ -36.079 millions
Ensign Group Inc-40.04%$ -40.039 millions
Tearlab Corp-41.34%$ -41.344 millions
Moleculin Biotech Inc -44.54%$ -44.539 millions
Perrigo Company Plc-45.57%$ -45.572 millions
Biosig Technologies Inc -47.70%$ -47.695 millions
Hoth Therapeutics Inc -47.70%$ -47.703 millions
Repligen Corp-49.89%$ -49.892 millions
Cymabay Therapeutics Inc -58.31%$ -58.311 millions
Chemocentryx Inc.-60.47%$ -60.470 millions
Community Health Systems Inc -62.96%$ -62.963 millions
Imac Holdings Inc -68.37%$ -68.367 millions
Societal Cdmo Inc -74.59%$ -74.595 millions
Healthlynked Corp -75.21%$ -75.213 millions
Agios Pharmaceuticals Inc -75.22%$ -75.222 millions
Seelos Therapeutics inc -78.43%$ -78.427 millions
Immucell Corp-80.01%$ -80.007 millions
Advanced Container Technologies Inc -81.70%$ -81.701 millions
Rezolute Inc -83.69%$ -83.693 millions
Surgalign Holdings Inc -85.24%$ -85.243 millions
Zoetis Inc -86.51%$ -86.508 millions
Remedent Inc -88.73%$ -88.728 millions
Spectrum Pharmaceuticals Inc -95.02%$ -95.021 millions
Nascent Biotech Inc-95.03%$ -95.033 millions
Vistagen Therapeutics Inc -95.72%$ -95.718 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com